Our purpose is to make medicines fit for tomorrow, to improve the lives of patients globally
By 2025, we will be one of the world’s fastest growing global specialty pharma companies, launching value-added medicines in defined disease areas.
That’s what we believe at Pharmanovia. We put patients and their families at the heart of our thinking, to see how we can enhance established medicines either by rediscovering, repurposing or re-engineering iconic brands to improve patient outcomes and experiences.
We continually assess our portfolio, taking the patient and clinician insights we gather to identify different therapies and treatment options, originating from both in-house development and through strategic partnerships.
Portfolio of iconic brands growing through operational and commercial excellence
Redevelopment of our portfolio using our life cycle management expertise
In-licensing of novel therapies that complement our portfolio
Targeted selection of acquisition candidates suitable for re-engineering
By 2025, we will be one of the world’s fastest growing global specialty pharma companies, launching value-added medicines in defined disease areas.
We are committed
We are agile
We are innovative
We are committed to working in a sustainable and ethical way, doing the right thing for people, communities and the environment.